Notice & Events

  • March 6, 2012 at 6:59 PM EDT

    Meeting Description: 

    ASH is pleased to introduce the fifth webinar of its 2011-2012 series, on the topic of Thrombosis and Cancer.

    This webinar is designed to provide a practical approach to the issue of thrombosis and cancer confronted by the busy practitioner on a daily basis.  First, we will explore risk assessment of VTE in cancer patients.  Second, we will review a practical approach to VTE treatment in cancer patients, emphasizing its unique challenges. Finally, we will address the specific issues of antithrombotic management in cancer patients with centrally-placed venous access.  There will be adequate time for questions and answers at the end of the program.

    Presentations and Speakers:

    Alok A. Khorana, MD, FACP (James P. Wilmot Cancer Center)

    Dr. Khorana will focus on understanding risk factors and biomarkers for VTE in patients with cancer, and conducting risk assessment using a risk score. The emphasis will be on recent data, updates and controversies regarding selecting the appropriate patients for thromboprophylaxis of cancer-associated VTE.

    Agnes Y. Lee, MD, MSc, FRCPC (Diamond Health Care Centre)

    Dr. Lee will review the current treatment options for treating cancer patients with venous thromboembolism.  The evidence, advantages and limitations, and practical insights of various anticoagulants will be shared.

    Elie Akl, MD (University of Buffalo)

    Dr. Akl will discuss thromboprophylaxis in cancer patients with central venous catheters, including treatment of VTE in cancer patients with central venous catheters.

  • January 5, 2012 at 9:35 AM EDT

     

    OUT DOOR & LAB (From 9.00 am to 1.00pm)

     

    Day

    Consultant

    Saturday

    Dr. Akhil Ranjon Biswas

    Sunday

    Dr. Akhil Ranjon Biswas

    Monday

    Dr. Akhil Ranjon Biswas

    Tuesday

    Dr. Tasneem Ara

    Wednesday

    Dr. Tasneem Ara

    Thursday

    Dr. Tasneem Ara



    WARD ROUND (From 10.30 am to 12.30 pm)

     

    Day

    Consultant

    Saturday

    Dr. M.A. Khan

    Sunday

    Dr. Salma Afrose

    Monday

    Dr. Tasneem Ara

    Tuesday

    Dr. Akhil Ranjon Biswas

    Wednesday

    Dr. M.A. Khan

    Thursday

    Dr. Salma Afrose



    Prof. (Dr.) M. A. Khan

    Head of the department,

    Department of Haematology,

    Dhaka Medical College Hospital.

  • January 5, 2012 at 9:27 AM EDT

     

     

     

    NAME

    PLACEMENT

    Dr. Forhad                                   

    Laboratory

     

    Dr Nazim   

     

     

     

    Laboratory

     

     

    Dr. Nipu

     

     

    Female paying + nonpaying

     

     

    Dr. Mafruha

     

    Dr. Zulfia

     

     

     

    Cabin

     

    Medicine Course

     

     

    Dr. Humayra

    Ward=313+ MMD

     

     

    Dr. Kamruzzaman

     

     

     

     

    FCPS Course

     

     

    Dr. Manir


     

     

     

    FCPS Course

     

     APL Slide

    Prof. M.A. Khan

    Head of the Dept. of Haematology 

     

     

  • January 5, 2012 at 8:58 AM EDT

    DAY

    NAME

    Saturday

    Dr. Kamrul &
    Dr.Forhad

    Sunday

    Dr. Tangia &
    Dr. Nazim

    Monday

    Dr. Ashraful

    Tuesday

    Dr. Nahid &
    Dr. Nazneen

    Wednesday

    Dr. Zubayer

    Thursday

    Dr. Dr. Kamruzzaman &

    Dr. Mynul

     

     

    Prof. M. A. Khan

    Head of the Dept. of Haematology 

Blog

  • August 6, 2012 at 8:42 PM EDT

     

    Reticulocytosis is seen in all except :
    a) P.N.H.
    b) Hemolysis
    c) Nutritional anemia
    d) Dyserythropoietic syndrome

    Correct answer : c) Nutritional anemia

    A 21 year old male presents with anemia and mild hepatosplenomegaly. His hemoglobin is 5 gm/dL history of single blood transfusion is present till date. Most probable diagnosis is :
    a) Thalassemia major
    b) Thalassemia minor
    c) Thalasseniia intermedia
    d) Autoimmune hemolytic anemia

    Correct answer : d) Autoimmune hemolytic anemia

    A patient presents with increased serum ferritin, decreased TIBC, increased serum iron, % saturation increased. Most probable diagnosis is
    a) Anemia of chronic disease
    b) Sideroblastic anemia
    c) Iron deficiency anemia
    d) Thalassemia minor

    Correct answer : b) Sideroblastic anemia

    Earliest phenotypic manifestation of Idiopathic hereditary hemochromatosis is :
    a) Post prandial increase in serum iron concentration
    b) Elevated serum ferritin level
    c) Slate grey pigmentation of skin
    d) Increased transferrin saturation

    Correct answer : d) Increased transferrin saturation

  • January 18, 2012 at 1:08 PM EDT

    011812092435011812093020011812093324

    Our professors introduced with new director today.
  • January 18, 2012 at 12:56 PM EDT

     

    Most heartiest congratulation & best wishes to the doctors who have passed FCPS-II today.


    Department of Hematology, DMCH


  • January 17, 2012 at 12:28 PM EDT